On the metabolism of [3H]noradrenaline in different compartments of rat brain with respect to the role of catechol-O-methyltransferase
- PMID: 6693903
- DOI: 10.1111/j.1471-4159.1984.tb02751.x
On the metabolism of [3H]noradrenaline in different compartments of rat brain with respect to the role of catechol-O-methyltransferase
Abstract
Rats were pretreated with either reserpine or desmethylimipramine, either alone or in combination with tropolone. At either 10 min or 1 h after the intraventricular injection of [3H]noradrenaline, in several brain regions the complete metabolic patterns were determined: normetanephrine; the glycol metabolites (methylated and nonmethylated) and their sulfate conjugates; and the acidic metabolites (methylated and non-methylated). A reserpine-induced increase in the turnover of [3H]noradrenaline caused a transient increase of the catechol glycol followed by elevated levels of the two glycol sulfates. The stimulated [3H]noradrenaline turnover if achieved by desmethylimipramine caused a transient increase of normetanephrine and initially lowered values of catechol glycols (both free and sulfated), which were followed by elevated levels. Drug-pretreated rats compensated for the inhibition of catechol-O-methyl-transferase by tropolone in different ways: Reserpine caused an early increase of the catechol glycol beyond the measurements in other treatment groups, whereas desmethylimipramine increased the nonmethylated carboxylic acid and glycol sulfates rather slowly to levels beyond those of other groups. The results support the existence of two compartments with a fast metabolism (an intraneuronal monoamine oxidase compartment and an extraneuronal catechol-O-methyltransferase compartment). In addition, there seems to exist another extra-neuronal space with a slow, monoamine oxidase-dependent noradrenaline turnover.
Similar articles
-
Glial alpha 2-receptors probably inhibit the high-affinity uptake of noradrenaline into astrocytes in the rat brain in vivo.Neurochem Res. 1995 Mar;20(3):291-7. doi: 10.1007/BF00969545. Neurochem Res. 1995. PMID: 7609828
-
On the recovery of [3H]noradrenaline from different metabolic compartments of rat brain with respect to the role of catechol-O-methyltransferase.J Neurochem. 1984 Mar;42(3):781-7. doi: 10.1111/j.1471-4159.1984.tb02750.x. J Neurochem. 1984. PMID: 6693902
-
Time course of the metabolite patterns of intraventricularly injected [3H]noradrenaline in rat brain regions.J Neurochem. 1986 Oct;47(4):1132-40. doi: 10.1111/j.1471-4159.1986.tb00731.x. J Neurochem. 1986. PMID: 3746298
-
Metabolism of centrally released noradrenaline by extraneuronal monoamine oxidase and catechol-O-methyltransferase.Brain Res. 1976 Apr 23;106(2):403-6. doi: 10.1016/0006-8993(76)91037-4. Brain Res. 1976. PMID: 1276880 No abstract available.
-
The influence of inhibition of catechol-O-methyl transferase or of monoamine oxidase on the extraneuronal metabolism of 3H-(-)-noradrenaline in the rat heart.Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):285-92. doi: 10.1007/BF00506238. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6514013
Cited by
-
Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):26-33. doi: 10.1007/BF00633193. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3951564
-
Glial alpha 2-receptors probably inhibit the high-affinity uptake of noradrenaline into astrocytes in the rat brain in vivo.Neurochem Res. 1995 Mar;20(3):291-7. doi: 10.1007/BF00969545. Neurochem Res. 1995. PMID: 7609828
-
Brain cortical tissue levels of noradrenaline and its glycol metabolites: effects of ischemia and postischemic administration of idazoxan.Exp Brain Res. 1992;90(3):551-6. doi: 10.1007/BF00230938. Exp Brain Res. 1992. PMID: 1358670
MeSH terms
Substances
LinkOut - more resources
Full Text Sources